X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

DEATH OF INTERNATIONAL REGISTRATION

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

CANCELLED SECTION 71

TEAS CHANGE OF CORRESPONDENCE RECEIVED

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

FINAL REFUSAL MAILED

FINAL REFUSAL WRITTEN

AMENDMENT FROM APPLICANT ENTERED

PAPER RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

NON-FINAL ACTION MAILED

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

ASSIGNED TO EXAMINER

AMENDMENT FROM APPLICANT ENTERED

PAPER RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY IB

NON-FINAL ACTION MAILED

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB